Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on April 22, 2025
Gilat Receives Over $15 Million in Orders from Leading Satellite Operators
GlobeNewswire
·
April 22, 2025
PETAH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Commercial Division received over $ …
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire
·
April 22, 2025
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO …
PolyPid to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 22, 2025
PETACH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in a …
Emerita Intersects 10.8 Meters Grading 4.8% Copper, 1.4 g/t Gold and 8.9 Meters Grading 1.1% Copper, 1.2 g/t Gold at El Cura Deposit
GlobeNewswire
·
April 22, 2025
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) continues to intersect copper-gold mineralization with associated zinc-lead-silver at its ongoing drilling campaign at …
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
GlobeNewswire
·
April 22, 2025
Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated patients with uncontrolled hypertension …
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 22, 2025
BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire
·
April 22, 2025
TORONTO and HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Newcore Gold Drilling Intersects 2.50 g/t Gold over 15.0 Metres and 3.00 g/t Gold over 10.0 metres at the Enchi Gold Project, Ghana
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …
NNN Community RelauNNNch: A New Era Begins on Base
GlobeNewswire
·
April 22, 2025
DUBAI, United Arab Emirates, April 22, 2025 (GLOBE NEWSWIRE) -- NNN, the decentralized security and community-powered ecosystem, has officially launched its presale and begun its migration to the Base blockchain. This strategic move marks a new chapter for …
Allot Launches New Off-network Cybersecurity Solution, Part of its 360-degree Protection Platform
GlobeNewswire
·
April 22, 2025
Hod Hasharon, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative security-as-a-service (SECaaS) and network intelligence solutions for communication service providers and enterprises, …
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
GlobeNewswire
·
April 22, 2025
Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement …
Fortuna to release first quarter 2025 financial results on May 7, 2025; Conference call at 12 p.m. Eastern time on May 8, 2025
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it will release its financial statements and MD…
Telix Reports US$186M Q1 Revenue, Up 62% YOY
GlobeNewswire
·
April 22, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 ( …
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful …
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
GlobeNewswire
·
April 22, 2025
DUBAI, UAE, April 22, 2025 (GLOBE NEWSWIRE) -- Avenix Fzco has introduced Pivozon, an advanced EA designed for XAU/USD traders who prefer the structure and discipline of H1-based swing trading. There's a noticeable shift in the forex trading world. A …
Integral Metals Welcomes Shervin Pishevar as an Advisor to the Company
GlobeNewswire
·
April 22, 2025
CALGARY, Alberta, April 22, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the addition of Shervin Pishevar as an Advisor to the Company. With his extensive experience …
HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
GlobeNewswire
·
April 22, 2025
HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in …
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
GlobeNewswire
·
April 22, 2025
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the NYSE …